Endo Health Rises On Report It May Put Itself Up for Sale

Endo Health Solutions Inc., (ENDP) the maker of the painkiller Lidoderm, rose the most in seven years after a report said the drugmaker may sell itself.

The shares of the Chadds Ford, Pennsylvania-based company climbed 13 percent to $32.40 at 2:46 p.m. New York time after reaching $33.32 in the highest intraday increase since June 2005. Reuters cited unidentified sources in its article.

Blaine Davis, a spokesman for Endo, didn’t immediately return a voice-mail message seeking comment about the possible sale.

To contact the reporter on this story: Ryan Flinn in San Francisco at rflinn@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.